Daily Care News for January 25, 2017
advertisement
- “Let the Algorithm Do the Work”: Reduction of Hypoglycemia Using Sensor-Augmented Pump Therapy with Predictive Insulin Suspension (SmartGuard) in Pediatric Type 1 Diabetes Patients.
- Poor Adherence to Ketone Testing in Patients With Type 1 Diabetes.
- Dapagliflozin in Patients with Type 1 Diabetes: A post-hoc analysis of the effect of insulin dose adjustments on 24-hour continuously monitored mean glucose and fasting beta-hydroxybutyrate levels from a Phase IIa pilot study.
- Ketosis and Diabetic Ketoacidosis in Response to SGLT2 Inhibitors: Basic Mechanisms and Therapeutic Perspectives.
- Clinical, behavioral and social indicators for poor glycemic control around the time of transfer to adult care: a longitudinal study of 126 young people with diabetes.
- Comparison of Insulin Glargine 300 U/mL and 100 U/mL in Adults With Type 1 Diabetes: Continuous Glucose Monitoring Profiles and Variability Using Morning or Evening Injections.
- Comparing effects of insulin analogues and human insulin on nocturnal glycemia in hypoglycaemia-prone people with Type 1 diabetes. See also Analogue insulin better for night-time hypos in type 1 diabetes, researchers say.
- Exercise management in type 1 diabetes: a consensus statement. Full text available with free registration. See also Safe exercise guidelines for type 1 diabetes by international team led by York U researcher and JDRF PEAK Experts Develop First-Ever Consensus Guidelines on Safe Exercise for People with Type 1 Diabetes.
- Translating HbA1c measurements into estimated average glucose values in pregnant women with diabetes.
- Sulfonylurea challenge test in subjects diagnosed with type 1 diabetes mellitus.
